Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Centrosome aberrations in hematological malignancies.

Alwin Krämer1, Kai Neben, Anthony D Ho

  • 1Danish Cancer Society, Institute of Cancer Biology, Department of Cell Cycle and Cancer, Strandboulevarden 49, 2100 Kopenhagen, Denmark. ajk@cancer.dk

Cell Biology International
|July 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<sup>68</sup>Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of <sup>68</sup>Ga-FAPI-46 with <sup>18</sup>F-FDG in 13 patients.

European journal of nuclear medicine and molecular imaging·2026
Same author

(Un-)Known Chances: Emerging Hope for Cancer of Unknown Primary - Highlights from ESMO 2025 and the First International Cancer of Unknown Primary Meeting.

Oncology research and treatment·2026
Same author

Etiology of TP53 mutated complex karyotype acute myeloid leukemia.

Leukemia·2025
Same author

Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial.

Blood·2025
Same author

Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatment.

Nature reviews. Clinical oncology·2025
Same author

Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype.

Nature genetics·2024
Same journal

Mitochondria-Associated Endoplasmic Reticulum Membranes in Cancer: Hubs for Tumor Progression and Therapeutic Vulnerabilities.

Cell biology international·2026
Same journal

Small Extracellular Vesicle-TLN1 Modulates Gastric Cancer Cells and Remodels Lymphatic Endothelial Cells Through AKT Activation to Potentiate Lymphatic Metastasis.

Cell biology international·2026
Same journal

Adipose-Derived Stem Cells Differentiate Into Insulin-Producing Cells in 2D Culture With Photobiomodulation: A Comparative Analysis of Wavelength and Fluence Parameters.

Cell biology international·2026
Same journal

Impaired Neurosphere Formation as a Functional Readout of Aberrant EGFR Signaling Kinetics in Olfactory Neural Progenitors From Patients With Schizophrenia.

Cell biology international·2026
Same journal

Mechanobiology-Driven Metabolic Reprogramming: Integrative Roles of YAP/TAZ Signaling and Extracellular Matrix Dynamics.

Cell biology international·2026
Same journal

NPC2 Regulates Glioblastoma Cholesterol Metabolism and Malignant Behavior via GPX4-Linked Ferroptosis.

Cell biology international·2026
See all related articles

Centrosome abnormalities, crucial for cell division, are common in hematological malignancies and linked to disease aggressiveness. Understanding their causes and consequences is key to developing new treatments.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Hematology

Background:

  • Centrosomes organize microtubules and are vital for cell division and genome stability.
  • Precise centrosome duplication, regulated by cyclin-dependent kinase 2 (cdk2), ensures accurate chromosome separation.
  • Aberrations in centrosome number or structure are hallmarks of solid tumors and increasingly recognized in hematological malignancies.

Purpose of the Study:

  • To review recent advances in understanding the causes and consequences of centrosome aberrations in hematological malignancies.
  • To explore the link between centrosome abnormalities and clinical aggressiveness in blood cancers.
  • To discuss molecular mechanisms underlying centrosome aberrations.

Main Methods:

  • Literature review of recent research on centrosome biology and hematological malignancies.

Related Experiment Videos

  • Analysis of studies investigating centrosome abnormalities in various blood cancers.
  • Discussion of proposed models for the development of centrosome aberrations.

    • Main Results:

    • Centrosome abnormalities are prevalent in diverse hematological malignancies, including leukemias and lymphomas.
    • A correlation exists between centrosome aberrations, karyotype instability, and clinical aggressiveness in myeloid malignancies and certain lymphomas.
    • Two primary models for centrosome aberration development are proposed: arising from mitotic errors or preceding genomic instability.

    Conclusions:

    • Centrosome aberrations are significant features of hematological malignancies with implications for disease progression.
    • Further research into the molecular mechanisms of centrosome aberrations is crucial for therapeutic strategies.
    • Understanding these aberrations offers insights into maintaining genome integrity in cancer.